AGNG


Aging Population ETF

Reasons to Consider AGNG

Long-Term Growth Potential

Humans are living longer than ever, with forecasts suggesting the global population of adults age 60+ could double to more than 2bn by 2050.1

Demographics Drive Consumption

With a ballooning senior population, particularly in western countries, we expect to see waves of innovation catering to their distinct consumer preferences.

Unconstrained Approach

The Aging Population theme is a global trend, affecting a wide range of industries. AGNG invests accordingly, offering exposure to companies regardless of sector or geographic classification.

1WHO, Oct 2021

Key Information As of 07/01/22

Inception Date 05/09/16
Total Expense Ratio 0.50%
Net Assets $50.33 million
NAV $25.55
Fact Sheet

ETF Summary

The Global X Aging Population ETF (AGNG) seeks to invest in companies positioned to serve the world’s growing senior population through exposure to health care, pharmaceuticals, senior living facilities and other sectors that contribute to increasing lifespans and extending quality of life in advanced age.

ETF Objective

The Global X Aging Population ETF (AGNG) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Aging Population Thematic Index.

Trading Details As of 07/01/22

Ticker AGNG
Bloomberg Index Ticker ILNGRNT
CUSIP 37954Y772
ISIN US37954Y7720
Primary Exchange Nasdaq
Shares Outstanding 1,970,000
Number of Holdings 99
30-Day Median Bid-Ask Spread 0.27%

Distributions As of 07/01/22

30-Day SEC Yield 0.84%
Distribution Frequency Semi-Annually

ETF Prices As of 07/01/22

NAV $25.55 Daily Change $0.33 1.32%
Market Price $25.70 Daily Change $0.41 1.60%

Performance History

As of recent
(03/31/22)
As of recent
(03/31/22)
Fund NAV Market Price Index
1 Year 4.32% 4.02% 4.46%
3 Years 10.88% 10.69% 11.09%
5 Years 12.10% 11.95% 12.34%
Since Inception 12.17% 12.57% 12.45%
1 Year -9.88% -9.60% -9.99%
3 Years 9.80% 9.62% 10.01%
5 Years 8.79% 8.67% 9.01%
Since Inception 10.12% 10.56% 10.39%
Year-to-Date -0.59% -0.52% -0.57%
1 Month 5.83% 5.91% 5.82%
3 Months -0.59% -0.52% -0.57%
Since Inception 96.77% 100.92% 99.78%
Year-to-Date -9.40% -9.06% -9.36%
1 Month -1.95% -1.73% -1.94%
3 Months -3.55% -3.18% -3.53%
Since Inception 79.33% 83.67% 82.12%

Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance of the Fund, when observed, is unusual and investors should not expect such performance to be repeated.

Top Holdings As of 07/01/22

Net Assets (%) Ticker Name SEDOL Market Price ($) Shares Held Market Value ($)
3.62 LLY ELI LILLY & CO 2516152 324.71 5,607 1,820,648.97
3.48 BMY BRISTOL-MYERS SQUIBB CO 2126335 76.84 22,761 1,748,955.24
3.36 JNJ JOHNSON & JOHNSON 2475833 179.52 9,409 1,689,103.68
3.35 AMGN AMGEN INC 2023607 245.55 6,860 1,684,473.00
3.25 AZN ASTRAZENECA PLC-SPONS ADR 2989044 65.95 24,822 1,637,010.90
3.23 NOVOB DC NOVO NORDISK A/S-B BHC8X90 109.59 14,816 1,623,676.90
3.10 ABBV ABBVIE INC B92SR70 153.80 10,149 1,560,916.20
3.02 ALC SW ALCON INC BJT1GR5 69.99 21,686 1,517,851.15
2.92 WELL WELLTOWER INC BYVYHH4 83.21 17,659 1,469,405.39
2.90 BSX BOSTON SCIENTIFIC CORP 2113434 38.01 38,446 1,461,332.46
2.87 RO SW ROCHE HOLDING AG-BR 7108918 386.19 3,738 1,443,587.85
2.86 REGN REGENERON PHARMACEUTICALS 2730190 595.40 2,420 1,440,868.00
2.81 MDT MEDTRONIC PLC BTN1Y11 91.38 15,463 1,413,008.94
2.77 EW EDWARDS LIFESCIENCES CORP 2567116 97.39 14,305 1,393,163.95
2.68 4519 JP CHUGAI PHARMA CO 6196408 25.73 52,336 1,346,408.14
2.61 SYK STRYKER CORP 2853688 203.86 6,442 1,313,266.12
2.41 SGEN SEAGEN INC BLPK4D2 180.11 6,730 1,212,140.30
2.26 BIIB BIOGEN INC 2455965 210.63 5,410 1,139,508.30
2.09 DXCM DEXCOM INC B0796X4 77.63 13,516 1,049,247.08
2.05 4503 JP ASTELLAS PHARMA INC 6985383 15.24 67,578 1,029,562.32
1.65 4543 JP TERUMO CORP 6885074 29.70 27,952 830,191.88
1.64 ZBH ZIMMER BIOMET HO 2783815 107.27 7,704 826,408.08
1.59 GMAB DC GENMAB A/S 4595739 329.77 2,419 797,723.15
1.54 VTR VENTAS INC 2927925 52.74 14,705 775,541.70
1.49 SOON SW SONOVA HOLDING AG-REG 7156036 321.41 2,325 747,282.64
1.39 STMN SW STRAUMANN HOLDING AG-REG BQ7ZV06 119.70 5,860 701,435.76
1.39 068270 KS CELLTRION INC B0C5YV1 137.97 5,076 700,353.80
1.26 INCY INCYTE CORP 2471950 77.67 8,143 632,466.81
1.25 BGNE BEIGENE LTD-ADR BYYWPW6 166.95 3,775 630,236.25
1.22 UCB BB UCB SA 5596991 85.83 7,158 614,401.45
1.15 PODD INSULET CORP B1XGNW4 226.46 2,547 576,793.62
1.06 FME GR FRESENIUS MEDICA 5129074 49.44 10,782 533,094.56
0.88 SN/ LN SMITH & NEPHEW PLC 0922320 13.81 32,148 444,039.55
0.87 TFX TELEFLEX INC 2881407 255.09 1,725 440,030.25
0.87 3692 HK HANSOH PHARMACEU BJYKB72 2.02 217,643 439,343.83
0.85 ABMD ABIOMED INC 2003698 254.56 1,674 426,133.44
0.78 UTHR UNITED THERAPEUTICS CORP 2430412 238.00 1,658 394,604.00
0.69 NBIX NEUROCRINE BIOSC 2623911 99.25 3,500 347,375.00
0.67 DEMANT DC DEMANT A/S BZ01RF1 38.01 8,826 335,438.42
0.66 AGL AGILON HEALTH INC BLR4TK4 22.60 14,742 333,169.20
0.65 COH AU COCHLEAR LTD 6211798 135.18 2,418 326,863.41
0.59 DVA DAVITA INC 2898087 83.11 3,540 294,209.40
0.56 NVCR NOVOCURE LTD BYSS4X4 73.30 3,837 281,252.10
0.52 EXAS EXACT SCIENCES CORP 2719951 41.13 6,402 263,314.26
0.52 AMP IM AMPLIFON SPA B14NJ71 31.58 8,321 262,776.61
0.50 EXEL EXELIXIS INC 2576941 21.57 11,731 253,037.67
0.50 OHI OMEGA HEALTHCARE 2043274 28.79 8,777 252,689.83
0.48 1858 HK BEIJING CHUNLI-H BVVPXP6 1.72 140,916 241,718.57
0.45 HALO HALOZYME THERAPEUTICS INC 2975098 44.48 5,055 224,846.40
0.43 853 HK MICROPORT SCIENTIFIC CORP B676TW7 2.90 73,902 214,260.56
0.40 RDUS RADIUS HEALTH INC BM68KK1 10.48 19,104 200,209.92
0.40 1789 HK AK MEDICAL HOLDINGS LTD BFD6SZ0 0.75 265,789 199,167.73
0.39 2500 HK VENUS MEDTECH -H BL6V047 2.23 87,040 194,116.11
0.38 GN DC GN STORE NORD A/S 4501093 36.18 5,254 190,068.51
0.37 NHI NATL HEALTH INVESTORS INC 2626125 61.59 3,042 187,356.78
0.36 1302 HK LIFETECH SCIENTIFIC CORP BV9FKS0 0.37 497,192 183,116.14
0.36 LHCG LHC GROUP INC B06DT50 155.05 1,162 180,168.10
0.36 LTC LTC PROPERTIES INC 2498788 38.82 4,605 178,766.10
0.35 SBRA SABRA HEALTH CAR B5NLBP6 14.29 12,317 176,009.93
0.35 MNKD MANNKIND CORP BF081J4 3.98 43,718 173,997.64
0.34 NHC NATIONAL HEALTHCARE CORP 2139731 70.89 2,435 172,617.15
0.34 TBPH THERAVANCE BIOPHARMA INC BMNDK09 9.73 17,636 171,598.28
0.34 4547 JP KISSEI PHARM CO 6494061 19.43 8,753 170,052.36
0.33 AERI AERIE PHARMACEUTICALS INC BFRTDG1 8.36 19,885 166,238.60
0.32 8086 JP NIPRO CORP 6641599 7.91 20,508 162,254.76
0.32 DNLI DENALI THERAPEUTICS INC BD2B4V0 31.24 5,127 160,167.48
0.32 NUVA NUVASIVE INC B00GJC2 50.26 3,184 160,027.84
0.32 ITGR INTEGER HOLDINGS CORP BD06LM7 72.00 2,212 159,264.00
0.31 ANGO ANGIODYNAMICS INC B00CR04 19.54 7,960 155,538.40
0.31 SILK SILK ROAD MEDICAL INC BGHVXJ7 38.94 3,989 155,331.66
0.31 2186 HK LUYE PHARMA GROUP LTD BNQ4GF3 0.33 469,424 154,343.96
0.31 EKTAB SS ELEKTA AB-B SHS B0M42T2 6.98 22,023 153,670.86
0.31 FGEN FIBROGEN INC BSDRYR8 11.40 13,463 153,478.20
0.30 ENSG ENSIGN GROUP INC/THE B1YWPP8 75.69 2,019 152,818.11
0.29 PHM SM PHARMA MAR SA BMW2GT8 71.18 2,082 148,201.22
0.29 RYM NZ RYMAN HEALTHCARE LTD 6161525 5.40 27,301 147,462.75
0.29 SGHT SIGHT SCIENCES INC BN2T5Q6 10.14 14,399 146,005.86
0.29 MMSI MERIT MEDICAL SYSTEMS INC 2580555 54.96 2,622 144,105.12
0.28 CSH-U CN CHARTWELL RETIRE B8S8C94 8.63 16,418 141,660.44
0.28 CANO CANO HEALTH INC BN0WWW2 4.60 30,650 140,990.00
0.28 SIA CN SIENNA SENIOR LIVING INC BWTYXH4 10.05 13,788 138,600.21
0.27 LIVN LIVANOVA PLC BYMT0J1 63.30 2,150 136,095.00
0.27 AMED AMEDISYS INC 2024332 110.82 1,220 135,200.40
0.27 GKOS GLAUKOS CORP BYMWL19 47.66 2,835 135,116.10
0.27 ALEC ALECTOR INC BJ4LDC4 11.02 12,173 134,146.46
0.27 AGIO AGIOS PHARMACEUTICALS INC BCBVTX1 23.36 5,718 133,572.48
0.26 AED BB AEDIFICA B1G5XP1 95.19 1,352 128,692.33
0.25 INGN INOGEN INC BJSVLL5 24.50 5,209 127,620.50
0.24 BPMC BLUEPRINT MEDICINES CORP BWY52P3 49.93 2,453 122,478.29
0.24 PNTG PENNANT GROUP INC/THE BKTC976 12.88 9,392 120,968.96
0.23 KORI FP KORIAN B1HKRM0 14.83 7,948 117,858.88
0.23 BKD BROOKDALE SR B0PZN33 4.53 25,366 114,907.98
0.22 DHC DIVERSIFIED HEAL BKRN595 1.89 59,304 112,084.56
0.21 ORP FP ORPEA 7339451 23.58 4,403 103,815.85
0.18 CMAX CAREMAX INC BMD9BG0 4.05 22,518 91,197.90
0.18 ACAD ACADIA PHARMACEU 2713317 14.37 6,293 90,430.41
0.18 ATEC ALPHATEC HOLDINGS INC BD60BG7 6.68 13,335 89,077.80
0.15 HRTX HERON THERAPEUTICS INC BJ0XLZ3 2.72 27,244 74,103.68
0.13 AMRN AMARIN CORP PLC -ADR 2301938 1.44 46,424 66,850.56
0.08 CASH 1.00 41,873 41,706.39
Holdings are subject to change.

Sector Breakdown As of 05/31/22

Sector Weight (%)
Health Care 93.2
Real Estate 6.8

Source: AltaVista Research, LLC

Country Breakdown As of 05/31/22

Country Weight (%)
United States 58.1
Switzerland 9.1
Japan 7.3
Denmark 5.8
Britain 5.1
China 3.5
Ireland 3.1
Belgium 1.5
South Korea 1.3
Germany 1.3
Australia 0.8
Other/Cash 3.1

Source: AltaVista Research, LLC

ETF Characteristics As of 07/01/22

Return on Equity 12.10%
Weighted Avg. Market Cap 87,439 M
2021 2022
Price-to-earnings 25.09 26.32
Price-to-book value 3.32 3.08

Source: AltaVista Research, LLC

ETF Risk Stats As of 07/01/22

Versus Beta
S&P 500 0.77
MSCI EAFE 0.75
MSCI Emg. Mkts 0.61
Standard Deviation 17.50%

Source: AltaVista Research, LLC

ETF Research

Investing involves risk, including the possible loss of principal. The investable universe of companies in which AGNG may invest may be limited. The Fund invests in securities of companies engaged in Healthcare, Pharmaceutical, Biotechnology and Medical Device sectors. These sectors can be affected by government regulations, expiring patents, rapid product obsolescence, and intense industry competition. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations. AGNG is non-diversified.

Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.

Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.

Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Indxx, nor does Indxx make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Indxx.

AGNG traded under the ticker LNGR from inception until April 1, 2021.

Back to Top